Core Viewpoint - WuXi AppTec (603259.SH) announced the sale of 30.3 million shares of WuXi AppTec Holdings through block trading, representing approximately 2.47% of its current total share capital, with a transaction value of about HKD 2.346 billion [1] Financial Impact - The net investment gain from the sale of WuXi AppTec Holdings shares is expected to impact the company's net profit after tax for the fiscal year 2025 by approximately RMB 1.679 billion, which accounts for over 10% of the latest audited net profit attributable to shareholders for the fiscal year 2024 [1] - Cumulatively, the net investment gain from the sale of WuXi AppTec Holdings shares for the fiscal year 2025 is projected to affect the company's net profit after tax by approximately RMB 4.351 billion [1]

Core Viewpoint - The company plans to sell a significant number of shares in various companies based on market conditions, which is expected to yield substantial profits exceeding 50% of its audited net profit from the last year [1] Group 1: Share Sales - The company intends to sell 8.686 million shares of Guizhou Yibai Pharmaceutical Co., Ltd. [1] - The company plans to sell 970,600 shares of Aorui De Optoelectronics Co., Ltd. [1] - The company will sell 7,716 shares of China Ping An Insurance (Group) Company [1] - The company aims to sell 4.7122 million shares of Hunan Erkang Pharmaceutical Co., Ltd. [1] Group 2: Financial Impact - The estimated profit from the sale of these shares, after deducting holding costs and related taxes, is projected to account for over 50% of the company's audited net profit from the previous year [1]